Acesso livre
Acesso livre

Medicina de Família

OMS recomenda o nirmatrelvir-ritonavir para o tratamento da COVID-19 e pede para uma maior distribuição geográfica.

25 Abr, 2022 | 12:47h

WHO recommends highly successful COVID-19 therapy and calls for wide geographical distribution and transparency from originator – World Health Organization

Ver também:

A living WHO guideline on drugs for covid-19 – The BMJ

Therapeutics and COVID-19: living guideline – World Health Organization

Conteúdos relacionados:

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19 – New England Journal of Medicine

Prescribing Nirmatrelvir–Ritonavir: How to Recognize and Manage Drug–Drug Interactions – Annals of Internal Medicine

The COVID-19 Treatment Guidelines Panel’s Statement on Potential Drug-Drug Interactions Between Ritonavir-Boosted Nirmatrelvir (Paxlovid) and Concomitant Medications – NIH COVID-19 Treatment Guidelines Panel

 

Comentário no Twitter

 


CDC alerta sobre novos casos de hepatite de origem desconhecida.

25 Abr, 2022 | 12:44h

News Release: CDC Alerts Providers to Hepatitis Cases of Unknown Origin – Centers for Disease Control and Prevention

Ver diretriz: Recommendations for Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology – Centers for Disease Control and Prevention

Comentários:

CDC issues health advisory about acute hepatitis in children – CNN

CDC Issues Alert for Hepatitis in Children With Adenovirus Infection – WebMD

Conteúdos relacionados:

Could Mysterious Hepatitis Cases be Triggered by COVID-19? – Health Policy Watch

Increase in hepatitis (liver inflammation) cases in children under investigation – UK Health Security Agency

U.S., U.K. investigating unusual cases of hepatitis in young children – STAT

Acute hepatitis of unknown aetiology – the United Kingdom of Great Britain and Northern Ireland – World Health Organization

Increase in acute hepatitis of unknown origin among children – United Kingdom – European Centre for Disease Prevention and Control

Mysterious liver illness seen in kids in US, Europe – Associated Press


Regulador de medicamentos do Reino Unido aconselha pacientes e médicos contra o uso de pregabalina durante a gestação em virtude de um possível risco aumentado de malformações congênitas.

25 Abr, 2022 | 12:40h

Pregabalin (Lyrica): findings of safety study on risks during pregnancy – Medicines and Healthcare products Regulatory Agency

Ver também: Pregabalin and risks in pregnancy – Medicines and Healthcare products Regulatory Agency

Fonte: Avoid prescribing pregabalin during pregnancy if possible, says UK drug regulator – The BMJ ($)

 

Comentário no Twitter

 


Estudo randomizado | Restrição calórica combinada com jejum intermitente (alimentação das 8 às 16 horas) não reduziu de maneira significativa a perda de peso em comparação à restrição calórica isolada em 12 meses (diferença – 1,8 kg; 95% IC, − 4 a 0,4; P = 0,11).

25 Abr, 2022 | 12:31h

Calorie Restriction with or without Time-Restricted Eating in Weight Loss- New England Journal of Medicine (link para o resumo – $ para o texto completo)

Comentário: Time-Restricted Eating No Better Than Cutting Calories for Obesity – HealthDay

Conteúdo relacionado: Intermittent Fasting and Obesity-Related Health Outcomes: An Umbrella Review of Meta-analyses of Randomized Clinical Trials – JAMA Network Open

 

Comentário no Twitter

 


Suplementos de vitamina D na gestação: quais são as evidências mais recentes?

25 Abr, 2022 | 12:21h

Vitamin D supplements in pregnancy: what’s the latest evidence? – Evidently Cochrane Blog

Estudo original: Vitamin D supplementation for women during pregnancy – Cochrane Library


Diretriz preliminar USPSTF | Mulheres na pós-menopausa não deveriam usar hormonioterapia para evitar problemas crônicos de saúde.

21 Abr, 2022 | 12:44h

Diretriz preliminar de recomendação: Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons – U.S. Preventive Services Task Force

Comunicado de imprensa: Task Force Issues Draft Recommendation Statement on Hormone Therapy for Preventing Chronic Conditions in Postmenopausal People – U.S. Preventive Services Task Force

Comentário: USPSTF Advises Against Hormone Therapy to Prevent Chronic Conditions – HealthDay


Estudo observacional sugere que a coprescrição de inibidores da fosfodiesterase tipo 5 (p. e., sildenafila) e nitratos orais não está associada a risco aumentado de desfechos cardiovasculares adversos em homens com doença cardíaca isquêmica.

21 Abr, 2022 | 12:39h

Adverse Events Associated With Coprescription of Phosphodiesterase Type 5 Inhibitors and Oral Organic Nitrates in Male Patients With Ischemic Heart Disease: A Case-Crossover Study – Annals of Internal Medicine

Comentários:

PDE5 inhibitors didn’t increase cardiovascular events in men on nitrates for heart disease – ACP Internist

PDE5 Inhibitors Prescribed for Men on Oral Nitrates for IHD – HealthDay


Estudos destacam o potencial da vacina contra meningite para prevenir a gonorreia.

21 Abr, 2022 | 12:35h

Comentário: Studies highlight meningitis vaccine’s potential against gonorrhea – CIDRAP

Comunicado de imprensa: Threat of untreatable gonorrhoea could be tackled using an existing meningitis vaccine – The Lancet

Estudo 1: Effectiveness of a serogroup B outer membrane vesicle meningococcal vaccine against gonorrhoea: a retrospective observational study – The Lancet Infectious Diseases (link para o resumo – $ para o texto completo)

Estudo 2: Effectiveness and impact of the 4CMenB vaccine against invasive serogroup B meningococcal disease and gonorrhoea in an infant, child, and adolescent programme: an observational cohort and case-control study – The Lancet Infectious Diseases (link para o resumo – $ para o texto completo)

Estudo 3: Public health impact and cost-effectiveness of gonorrhoea vaccination: an integrated transmission-dynamic health-economic modelling analysis – The Lancet Infectious Diseases


Covid não revelou todos os seus segredos. Aqui estão 6 mistérios que os especialistas esperam desvendar.

21 Abr, 2022 | 12:30h

Covid hasn’t given up all its secrets. Here are 6 mysteries experts hope to unravel – STAT


FDA alerta para os riscos associados aos testes de rastreamento pré-natal não invasivos – interpretação inadequada dos resultados pode levar a potenciais decisões médicas impróprias.

21 Abr, 2022 | 12:27h

FDA Warns of Risks Associated with Non-Invasive Prenatal Screening Tests – U.S. Food & Drug Administration

Ver também: Genetic Non-Invasive Prenatal Screening Tests May Have False Results: FDA Safety Communication – U.S. Food & Drug Administration


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.